This medical device company is due to report earnings on January 24, and recently reported that its revenue would be up about 17%, which is higher than analysts expected. Since then, five analysts have increased their earnings estimates for the company.
Intuitive Surgical, Inc. (ISRG)
From Shortex Market Letter
52wk high: 581.12
52 wk low: 380.00
Mkt Cap: $58.34B
EPS: 6.69
P/E: 76.32 Beta:1.20
Intuitive Surgical, Inc. (ISRG), the medical device maker of the da Vinci system has seen its stock doubling in the last 5 years, (up 23% in ’18).
As robotic assisted surgery is increasingly more embraced by the medical community sales in da Vinci have been increasing by 10%-15% per year, while 71% of the company’s total revenue stems from recovery sources.
ISRG reported Q3-18 earnings of $2.83/shr on revenue of $920.9M vs. consensus of $2.65/shr and revenue of $918.6M respectively. Its tremendous growth rate and established reputation for safety leaves its competition behind. It has been faced with periodic correction/retraction since its three-to-one stock split, reaching a high of 581.12 in Oct ’18. Plunging in repeated stages (570-551) to (539-520) to (518-501) to (499-478). Reversal to challenge 50&200-DMA (497-503) and upper-head resistance (563-574). Volatile.
RECOMMENDATION
Buying Range: 490-526
Nr Term Obj: 568
Inter Med Obj: 592
Stop Loss: 483
*Price as of intraday 01/11/19
Joseph Parnes, Shortex Market Letter, www.shortex.com, 800-877-6555, January 11, 2019